<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2761">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04341012</url>
  </required_header>
  <id_info>
    <org_study_id>19-001971</org_study_id>
    <nct_id>NCT04341012</nct_id>
  </id_info>
  <brief_title>Breath Analysis Based Disease Biomarkers of COVID-19 and Other Diseases</brief_title>
  <official_title>Development of a Breath Analysis Test for Disease Diagnosis and Prognosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to develop a clinical test based on breath analysis that can be
      used for disease diagnosis or prognosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will seek to collect and analyze breath samples from a broad range of patients to
      develop reference ranges and to refine the testing methods. Protocols for breath sample
      collection and algorithms for analysis will be developed. Samples will be collected from
      normal volunteers, persons with documented liver disease, organ transplant or with known
      COVID-19 test results.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 10, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Breath volatile organic compound profiles</measure>
    <time_frame>1 day</time_frame>
    <description>Analysis of profiles of volatile organic compounds present in exhaled breath</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Utility of breath profiles for disease diagnosis or prognosis</measure>
    <time_frame>14 days</time_frame>
    <description>Diagnosis or prognostic utility of breath volatile organic compound profiles</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Liver Diseases</condition>
  <condition>Liver Cancer</condition>
  <condition>COVID19</condition>
  <arm_group>
    <arm_group_label>Normal</arm_group_label>
    <description>No known medical conditions</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Liver Cirrhosis</arm_group_label>
    <description>Clinically diagnosed with cirrhosis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>COVID-19 tested</arm_group_label>
    <description>Persons with known test results for COVID-19 RNA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Other</arm_group_label>
    <description>Persons with other medical diagnosis, no known liver disease, negative for COVID-19</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Collection of breath sample</intervention_name>
    <description>Analysis of volatile organic compounds in breath</description>
    <arm_group_label>COVID-19 tested</arm_group_label>
    <arm_group_label>Liver Cirrhosis</arm_group_label>
    <arm_group_label>Normal</arm_group_label>
    <arm_group_label>Other</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects who are undergoing evaluation and obtaining clinical care at Mayo Clinic in
        Florida will be enrolled
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Able to provide informed consent

        Exclusion Criteria:

          -  None
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tushar Patel</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Robert Brannock</last_name>
    <phone>904-953-2000</phone>
    <email>brannock.robert@mayo.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Joanna Roopkumar</last_name>
    <phone>904-953-2000</phone>
    <email>roopkumar.joanna@mayo.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mayo Clinic Florida</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Brannock</last_name>
      <phone>904-953-2000</phone>
      <email>brannock.robert@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Tushar Patel, MBChB</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 7, 2020</study_first_submitted>
  <study_first_submitted_qc>April 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 10, 2020</study_first_posted>
  <last_update_submitted>April 9, 2020</last_update_submitted>
  <last_update_submitted_qc>April 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Tushar Patel</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

